Why Did Jupiter Neurosciences Plunge 12.59%?

On June 13, 2025, Jupiter Neurosciences, Inc. (JUNS) experienced a significant drop of 12.59% in pre-market trading, indicating a substantial decline in investor confidence.

Analysts have predicted a downside of -100.00% for Jupiter Neurosciences' stock based on their 12-month forecasts, suggesting a bleak outlook for the company's future performance.

The company has been marked as potentially delisted and may not be actively trading, which could further impact its stock price and investor sentiment.

Jupiter Neurosciences' stock price has been volatile, with a recent decline of 33.17% to $1.33, reflecting the market's concerns about the company's financial health and operational challenges.

Despite the negative outlook, some analysts predict that Jupiter Neurosciences' stock could reach a target price of $3.00, offering potential upside for investors willing to take on the risk.